Extra-Cellular Vesicles Derived from Thyroid Cancer Cells Promote the Epithelial to Mesenchymal Transition (EMT) and the Transfer of Malignant Phenotypes through Immune Mediated Mechanisms

Int J Mol Sci. 2023 Feb 1;24(3):2754. doi: 10.3390/ijms24032754.

Abstract

Thyroid cancer is the most common endocrine cancer, and its incidence is increasing in many countries around the world. Among thyroid cancers, the papillary thyroid cancer (PTC) histotype is particularly prevalent. A small percentage of papillary tumors is associated with metastases and aggressive behavior due to de-differentiation obtained through the epithelial-mesenchymal transition (EMT) by which epithelial thyroid cells acquire a fibroblast-like morphology, reduce cellular adhesion, increase motility and expression of mesenchymal proteins. The tumor microenvironment plays an important role in promoting an aggressive phenotype through hypoxia and the secretion of HMGB1 and other factors. Hypoxia has been shown to drastically change the tumor cell phenotype and has been associated with increasing metastatic and migratory behavior. Cells transfer information to neighboring cells or distant locations by releasing extracellular membrane vesicles (EVs) that contain key molecules, such as mRNAs, microRNAs (miRNAs), and proteins, that are able to modify protein expression in recipient cells. In this study, we investigated the potential role of EVs released by the anaplastic cancer cell line CAL-62 in inducing a malignant phenotype in a papillary cancer cell line (BCPAP).

Keywords: EMT; HMGB1; extra-cellular vesicles; microRNAs; thyroid cancer.

MeSH terms

  • Cell Line, Tumor
  • Cell Movement
  • Epithelial-Mesenchymal Transition* / genetics
  • Humans
  • Phenotype
  • Thyroid Cancer, Papillary / pathology
  • Thyroid Neoplasms* / pathology
  • Tumor Microenvironment

Grants and funding

This research was funded by grants Ateneo 2021 to S. Mardente and Ateneo 2020 to M. Tafani.